Splitero reports that homeowners in the Southeast saw equity soar, with Atlantic City gaining 97.8% since 2019, while some ...

Iran introduced a new pricing tier Saturday for its nationally subsidized gasoline, attempting to rein in spiraling costs for ...

Being bigger gives you that competitive advantage.” At the same time, mergers are becoming simpler. A surge in interest rates ...

We all went to medical school to practice medicine,” he says, “not to deal with insurance companies, not to fill out ...

If Asian countries are to break out of the middle-income trap, they must solve the problems that plague their cities. The ...

This is the introduction to Blighty, a weekly, subscriber-only newsletter in which our correspondents turn their gaze on the ...

Volatility tends to be high in times of crisis, when bond yields are spiking and stocks are lurching. Since his trade salvo ...

British voters, like others in Europe, are abandoning the centre parties for challengers, such as Reform and the Greens. But ...

New analysis challenges claims by the government of Greece of an economic miracle, revealing the reality behind growth, wages ...

IN THE BARRIO of Iztapalapa, on Mexico City’s eastern flank, the pavements stay busy even in the punishing afternoon sun. Street vendors hawk snacks from metal carts; waiters from corner taquerías ...

BRITAIN IS in alarming decline. Its paltry productivity growth, high borrowing costs and incoherent economic policy are bad enough. But the country also risks the collapse of the political centre ...

AFTER AMERICA, China is the world’s largest developer of new medicines. Its companies ran nearly a third of the planet’s clinical trials last year. That is up from just 5% a decade before (see chart 1 ...